StockWatch
·
ADROIT INDUSTRIES (INDIA) LTD · QQ2 FY-2027 · THE CALL

Strong QoQ growth, margin at target; capacity expansion on track

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsADROITINDAdroit Industries (India) Ltd31 Oct 2026 · 6 min read
Verdict

Buy

confidence 7/10

Credibility

Grade B

First earnings call post-IPO; Q2 delivery aligns with stated QoQ/H1 growth rates. No prior guidance to validate.

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong sequential growth (25% revenue, 14% PAT) with margin expansion to 28% EBITDA validates operational execution. Specific FY28 target (Rs. 250 Cr) and capacity expansion roadmap (Pithampur 1.8M units by Q4, Dewas 5,500 tonnes by Q1 FY28) provide visibility. Key risk: industrial/defence segments in testing phase (6-12 months), unproven revenue contribution.

₹42.7 Cr

Revenue · +null% YoY

₹8.5 Cr

Reported PAT · +51% YoY

Expanding

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Q2 revenue grew 25% sequentially

MET

Confirmed: Q2 revenue ₹42.67 Cr vs ₹34.14 Cr Q1 = 25.1% QoQ

PAT increased 14% sequentially

MET

Confirmed: Q2 PAT ₹8.5 Cr vs ₹7.46 Cr Q1 = 14.1% QoQ

EBITDA margin ~30% going forward

MET

Q2 EBITDA margin 28.0%, H1 margin 29.3%; in target range but not above it

Expecting revenue ~Rs. 250 crore FY28

OVERSTATED

Current run-rate ₹76.8 Cr H1 → ₹154 Cr annualized FY27; Rs. 250 Cr FY28 = 62% growth required

Earnings quality

What changed since the last call

Deltas vs. the prior call

Capacity roadmap crystallized

New

Pithampur: 900k→1.8M units (Q4 FY27); Dewas: 3k→5.5k tonnes (Q1 FY28). First concrete capex update post-IPO.

Order book disclosed

New

₹68-70 Cr order book, 78% export / 22% domestic. Provides visibility on near-term revenue.

New segment timelines

New

Industrial shafts scale in FY28; defence in testing (6-12 months). Earlier aspirational, now specific.

The Q&A

Analysts pressed on industrial/defence revenue realization (6-12 month test cycles), working capital at scale (248-249 days), and capacity utilization (93-94% forge, 81% Pithampur). MD held firm on execution roadmap and no-fundraising need; transparent on competitive landscape but guarded on new-segment timelines.

The exchanges that mattered

Industrial/defence scaling — Naman Desai, Sunrise India Growth Fund

Answered

Testing period 6-12 months; several shafts in testing now. Expect revenue ~Rs. 250 Cr FY28 across all segments.

Defence shaft specs — Prabir Adhikary, Fortune Asset Managers

Answered

Up to 3m length, up to 47,000 newton-metres torque. Competitors: Dana, Spyker, Cummins, Neapco. Differentiation through testing and validation.

Working capital at scale — Vignesh Iyer, Sequent Investments

Answered

Current cycle 248-249 days; expect improvement to 200-230 days. Can manage growth without additional funds.

Revenue/margin mix — Prithvi Bhatt, Abakkus Investment Managers

Answered

64-65% components, 35-36% finished shafts. Finished shafts 5-10% higher margin. Targeting universal joints by Nov 2026 to lift margins further.

Order book composition — Prithvi Bhatt, Abakkus Investment Managers

Answered

₹68-70 Cr order book; 78% export, 22% domestic. Strong geographic diversification.

International expansion — Sahil Shinde, Vaya Research

Answered

US and South America strongest. US subsidiary started operations; Memphis distribution centre. Targeting US, Canada, Colombia, Ecuador, Peru, Chile, Venezuela. European expansion in FY28.

Capacity utilization and FY31 vision — Prakshal Jain, Axiom Research

Answered

Forge 93-94%, Pithampur 81%. >Rs. 180 Cr FY27 target, Rs. 475-500 Cr FY31 mid-term vision with expanded platforms.

Guidance

Forward guidance and management's confidence

FY27: >Rs. 180 Cr full-year

Medium

Implies H2 needs ~₹103 Cr. H1 ₹77 Cr annualizes to ₹154 Cr; so >₹180 Cr needs 17% H2 acceleration.

FY28: ~Rs. 250 Cr

Medium

62% growth from ₹154 Cr annualized FY27. Contingent on capacity ramp (Q4 FY27, Q1 FY28) and new-segment revenue (industrial, defence).

FY31 mid-term: Rs. 475-500 Cr

Low

CAGR ~32-35% over 4 years. Assumes capacity fully utilized and new segments scaled. Aspirational; no detailed roadmap provided.

EBITDA margin: ~30% ±2pp going forward

High

Supported by disciplined procurement, manufacturing efficiency, pricing. Q2 at 28%, H1 at 29.3%; confidence in 30% level.

Finished shaft margins 5-10% higher than components

High

Value addition through assembly/balancing. Universal joints by Nov 2026 to add further uplift.

Pithampur: 900k → 1.8M units (by Q4 FY27)

High

Equipment ordered; machinery 50M Rs. purchased, 30M Rs. more on order. Phased ramp expected most operational in Q4.

Dewas: 3k → 5.5k tonnes (by Q1 FY28)

High

Equipment orders released; full ramp-up post-commissioning in Q1 FY28.

Universal joints in-house by Nov 2026

Medium

Currently procured; intent to manufacture in-house by year-end for margin improvement.

Risks the call surfaced

Ranked by how much they should concern a holder

New-segment revenue timing

High

Industrial and defence shafts in testing phase (6-12 months). Revenue ramp-up critical to achieve Rs. 250 Cr FY28 target. Delays would require aggressive catch-up.

Export concentration

Medium

H1 FY27: 82.4% of revenue from exports, with US 59.6% of export sales. Tariffs, trade friction, or US macro slowdown pose material revenue risk.

Working capital intensity

Medium

Current cycle 248-249 days; expected to improve to 200-230 days with India OEM mix. Inventory held in Canada/US for local shipment. Growth to Rs. 250 Cr FY28 would require significant incremental WC and capex.

Capacity ramp execution

Medium

Pithampur machining (900k→1.8M units by Q4 FY27) and Dewas forging (3k→5.5k tonnes by Q1 FY28) expansions critical to FY28 target. Installation, commissioning, ramp-up delays would crimp revenue.

Competitive intensity

Medium

Global competitors (Dana, Spyker, Cummins, Neapco) in propeller shaft market. New-segment entry (industrial, defence) faces entrenched players. Pricing power and customer stickiness unproven at scale.

Management

Score 7/10. Clear and transparent on product specs, capacity roadmap, and competitive landscape. MD provided specific technical details (shaft lengths, torque specs) and names competitors. Withheld minimal detail on new-segment timelines (understandable given testing phases). IPO capital deployment on schedule (Rs. 50 Cr purchased, Rs. 30 Cr on order). Q2 delivery aligns with stated sequential and YoY growth. No prior guidance misses to judge, but track record of margin expansion (22% FY26 → 28-29% H1 FY27) supports credibility.

What to watch next
  • 1 · Q4 FY27

    Pithampur machining capacity doubles to 1.8M units; ramp validation

  • 2 · Q1 FY28

    Dewas forging capacity expansion (3k to 5.5k tonnes) operational

  • 3 · Nov 2026

    Universal joints in-house manufacturing completed; margin uplift target

Key risk: industrial/defence segments in testing phase (6-12 months), unproven revenue contribution.

Informational and educational content only. Not investment advice.